Actinium Pharmaceuticals Inc. (Delaware)
Last updated September 27, 2026
Organization details
- Legal name
- Actinium Pharmaceuticals Inc. (Delaware)
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ATNM
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001388320
Board of directors
-
Ajit Shetty · DirectorSince 2023
-
C. David Nicholson · DirectorSince 2023
-
Jeffrey W. Chell · DirectorSince 2023
-
June Sherie Almenoff · DirectorSince 2024
-
Richard I. Steinhart · DirectorSince 2023
-
Sandesh Seth · Director · Chief Executive OfficerSince 2023
Chief executives
Sandesh Seth
· Chief Executive Officer
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via Richard I. Steinhart
- via June Sherie Almenoff
- via June Sherie Almenoff
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2025 | Sandesh Seth Director, Officer (Chief Executive Officer) | Shares withheld for tax | −120,900 | $1.71 | $206,739 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.